- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Specialises in
- Skin
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
After competing his medical and oncology training in Sydney, Dr Nick Coupe moved to Oxford to undertake a fellowship in early phase clinical trials. Here he developed an interest in skin cancer and lung cancer and as well as the development of new medications to treat cancer,
Dr Coupe was awarded a CRUK fellowship and subsequently completed a PhD within the University of Oxford investigating associations between a melanoma and the process of tumour driven new blood vessel formation (angiogenesis). The results of his work have been published. Dr Coupe has been a consultant at the Oxford NHS site since 2019, specialising in melanoma and lung cancer. He has also actively participated in teaching and leads the departmental governance division. Dr Coupe also maintains a strong link with early phase clinical trials and has written a protocol for a novel immunotherapy drug that is currently being tested in patients with lung cancer and melanoma for the very first time. The results have been presented at multiple international conferences and Dr Coupe has been interviewed to discuss the results. He has also been involved in maintaining guidelines to manage side effects for immunotherapy that are in use locally as well as nearby NHS trusts.
Dr Coupe has considerable experience in chemotherapy, targeted therapies and in particular, immunotherapies for the treatment of lung cancer and melanoma. He engages well with colleagues both within his trust and other sites and involves others where necessary to discuss difficult and challenging cases.
Dr Coupe is actively involved in clinical research, as a principal investigator of a number of clinical trials at the Churchill site.. He is interested in finding novel methods to track outcomes in real time in the hope of finding ways to improve overall service delivery. He has multiple publications (listed below) and is also interested in teaching and trainee supervision.
Areas of interest
Melanoma; cancer
Medical secretaries
- Ingrid Holloway
- Genesis Care Orion House Sandy Lane West Littlemore Oxford OX4 6LB
- 01865 237700
- ingrid.holloway@genesiscare.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
GenesisCare, Oxford (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
GenesisCare, Oxford (5-50)